Subscribe today to receive notice of our latest thought leadership, articles, blogs and updates.
![](/content/owca/owca/en/insights/_jcr_content/maincontent/image_copy.img.jpg/1666903580963.jpg)
Insights
Open conversations, knowledge sharing, and fresh ideas promote positive change and transparency
Our latest blog posts, articles and podcasts
Sharing information with the industry is an important part of our mission. Our subject matter experts translate today’s news into comprehensive informational pieces to help you better understand the impact of a recent industry update, trend, or issue.
![]() |
December 06, 2023 · Clinical Team
FDA warns that the antiseizure medications levetiracetam and clobazam may cause life-threatening adverse reaction. Read more... |
![]() |
December 06, 2023 · Public Policy & Regulatory Affairs Team
Brief updates include updated California’s workers’ comp treatment guidelines; and the Maryland workers’ comp fee guideline committee continues to discuss, in an open meeting process, the development of the state’s first pharmacy fee schedule. Read more... |
![]() |
November 29, 2023 · Clinical Team
In January, Optum clinical programs will adopt revised morphine equivalent dose (MED) conversion factors for the opioid analgesics hydromorphone, methadone, and tramadol to correlate with CDC Guidelines. However, these modifications are predicted to have little effect on Optum risk identification and clinical review programs. Read more... |
![]() |
November 17, 2023 · Clinical Team
Opvee® (nalmefene) nasal spray now available for emergency treatment of opioid overdoses, but currently non-formulary on all standard formularies until review by Optum P&T Committee. One unit of Opvee will likely be allotted per year by CMS. For WCMSAs, exposure for opioid antagonists like Opvee is unlikely to be significant. Read more... |
![]() |
November 15, 2023 · Public Policy & Regulatory Affairs Team
Brief notes include: Updated Washington workers’ comp outpatient formulary and mental health services provider list, updated Michigan workers’ comp health care rules, proposed New Mexico workers’ comp provider fee schedule and billing changes, updated Massachusetts workers’ comp hearing service rules, updated Maine workers’ comp reimbursement rates, and New York workers’ comp looks to update DMEPOS fee schedule. Read more... |
![]() |
October 25, 2023 · Public Policy & Regulatory Affairs Team
Brief updates in California workers’ comp PTSD presumption law amended and several other bill vetoed; Michigan legislation would significantly overhaul auto no-fault medical fee schedule law; Massachusetts to hold meetings on opioids; and Tennessee clarifies medical fee schedule updates. Read more... |
Page 5 of 7